PDS Biotechnology Corp
Clinical-stage immunotherapy firm developing T-cell activating treatments for disease.
PDSB | US
Overview
Corporate Details
- ISIN(s):
- US2798701098 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 303A COLLEGE ROAD EAST, 8540 PRINCETON
- Website:
- https://www.pdsbiotech.com
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
PDS Biotechnology Corp. is a clinical-stage immunotherapy company developing treatments designed to harness the body's T cells to combat disease. The company's proprietary Versamune® platform is a T-cell activating technology engineered to generate a potent and targeted immune response. The platform's mechanism involves delivering immune-activating agents, such as IL-12, into the tumor microenvironment to overcome cancer's defense mechanisms while stimulating a powerful T-cell attack. PDS Biotechnology's pipeline includes investigational immunotherapies for various cancers, including head and neck, prostate, and breast cancer, as well as potential vaccines for infectious diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PDS Biotechnology Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PDS Biotechnology Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PDS Biotechnology Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
